Bristol-Myers Squibb Business Finance Contracts & Agreements

80 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifteenth Supplemental Indenture, dated as of February 22, 2024, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as...
Indenture Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2024
Underwriting Agreement, dated February 14, 2024, among Bristol-Myers Squibb Company and the underwriters named therein
Underwriting Agreements
Bristol-Myers Squibb
Pharmaceuticals
NC
2024
Fourteenth Supplemental Indenture, dated as of November 13, 2023, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated...
Indenture Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2023
Underwriting Agreement, dated October 30, 2023, by and among Bristol-Myers Squibb Company and the underwriters named therein
Underwriting Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2023
Thirteenth Supplemental Indenture, dated as of March 2, 2022, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as of...
Indenture Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2022
Underwriting Agreement, dated February 15, 2022, among Bristol-Myers Squibb Company and the underwriters named therein
Underwriting Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2022
Amendment, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment and Waiver, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers Squibb...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Twelfth Supplemental Indenture, dated as of November 13, 2020, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as...
Indenture Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Underwriting Agreement, dated November 9, 2020, among Bristol-Myers Squibb Company and the underwriters named therein
Underwriting Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Term Loan Agreement, dated as of November 4, 2020, by and among Bristol-Myers Squibb Company, the lenders party thereto and Citibank, N.A., administrative agent
Loan Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Contingent Value Rights Agreement, dated as of November 20, 2019, by and between Bristol-Myers Squibb Company and Equiniti Trust Company, as trustee, including the Form of CVR...
Trust Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,...
Assignment Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Amendment, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
Amendment and Waiver, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
Purchase Agreement, dated May 7, 2019, by and between Bristol-Myers Squibb Company and the initial purchasers named therein
Purchase Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Three-Year Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and Morgan Stanley Senior...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
364-Day Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and, Citibank, N.A. and JPMorgan...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Term Loan Agreement, dated as of January 18, 2019, by and among Bristol-Myers Squibb Corporation, the lenders party thereto and Morgan Stanley Senior Funding, Inc., as...
Loan Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
Bridge Facility Commitment Letter, dated as of January 2, 2019, among Morgan Stanley Senior Funding, Inc., MUFG Bank, Ltd. and Bristol-Myers Squibb Company
Funding Agreements
Bristol-Myers Squibb
Pharmaceuticals
DE
2019
Extension to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2018
Extension to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2018
Amendment dated as of June 26, 2017, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company, the...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
VA
2017
Amendment and Waiver dated as of June 26, 2017, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2017
BRISTOL-MYERS SQUIBB COMPANY and THE BANK OF NEW YORK MELLON, Trustee NINTH SUPPLEMENTAL INDENTURE Dated as of February 27, 2017 to INDENTURE Dated as of June1, 1993 1.600% Notes...
Indenture Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2017
UNDERWRITING AGREEMENT, dated as of February 22, 2017 Bristol-Myers Squibb Company 1.600% Notes due 2019 3.250% Notes due 2027
Underwriting Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2017
AMENDMENT AND WAIVER
Waiver Agreements
Bristol-Myers Squibb
Pharmaceuticals
VA
2016
(FACE OF NOTE)
Note Agreements
Bristol-Myers Squibb
Pharmaceuticals
2015
(FACE OF NOTE)
Note Agreements
Bristol-Myers Squibb
Pharmaceuticals
2015
BRISTOL-MYERS SQUIBB COMPANY and THE BANK OF NEW YORK MELLON, Trustee EIGHTHSUPPLEMENTAL INDENTURE Dated as of May 5, 2015 to INDENTURE Dated as of June 1, 1993 1.000% Notes...
Indenture Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2015